IP Library › Granted Patent US 11,124,742
Granted Patent B2
US 11,124,742 · App. 16/644,176 · Granted Sep 21, 2021

Performance-enhanced protease variants III

Inventors: Nina Mussmann (Willich, DE); Susanne Wieland (Dormagen/Zons, DE); Daniela Herbst (Duesseldorf, DE); Inken Prueser (Duesseldorf, DE)
Assignee: Henkel AG & Co. KGaA
C11D3/38618C12N9/54C12Y304/21062
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,124,742
App. No.
16/644,176
Granted
Sep 21, 2021
Kind
B2
Abstract

An amino acid sequence may have at least 70% sequence identity to the amino acid sequence identified in SEQ ID No. 1 over its entire length, and (a) an amino acid substitution N130D on the position corresponding to the position 30 based on the numbering according to SEQ ID No. 1, and (b) an amino acid substitution on at least one of the positions corresponding to the positions 101, 133, 144, 224, 252 or 271, in each case based on the numbering according to SEQ ID No. 1. Such proteases are particularly suitable for having an improved cleaning performance.

Claims (45)

1. A protease comprising:

an amino acid sequence having at least 95% sequence identity with the amino acid sequence given in SEQ ID NO:1 over its entire length and having, in each case based on the numbering according to SEQ ID NO:1,

(a) an amino acid substitution N130D at the position corresponding to position 130, based on the numbering according to SEQ ID NO:1, and

(b) an amino acid substitution at at least one of the positions corresponding to positions 101, 133, 144, 224, 252, 271, or combinations thereof, in each case based on the numbering according to SEQ ID NO:1.

2. The protease according to claim 1 , wherein the at least one amino acid substitution according to (b) is selected from the group consisting of D101E, T133R, N144K, S224A, N252T, Q271E, or combinations thereof in each case based on the numbering according to SEQ ID NO:1.

3. The protease according to claim 1 , wherein the protease comprises:

(A) one of the following amino acid substitution variants, in each case based on the numbering according to SEQ ID NO:1:

(i) D101E, N130D, T133R, S224A, and Q271E;

(ii) D101E, N130D, N144K, N252T, and Q271E;

(iii) N130D, N144K, N252T, and Q271E; or

(iv) N130D, T133R, S224A, and Q271E; and/or

(B) an amino acid sequence according to one of SEQ ID Nos. 2-5.

4. A protease according to claim 1 as a starting molecule by one-time or multiple conservative amino acid substitution, wherein the protease comprises:

(i) an amino acid substitution N130D at the position corresponding to position 130 based on the numbering according to SEQ ID NO:1, and

(ii) at least one of the amino acid substitutions D101E, T133R, N144K, S224A, N252T or Q271E at the positions corresponding to positions 101, 133, 144, 224, 252 and 271 based on the numbering according to SEQ ID NO:1; and/or

(iii) wherein the protease optionally comprises an amino acid sequence matching the starting molecule over a length of at least 200, 210, 220, 230, 240, 250, 260, 270, or 275 contiguous amino acids.

5. A method for producing a protease, comprising:

(i) substituting an amino acid at the position corresponding to position 130 in SEQ ID NO:1 with the amino acid substitution 130D in a starting protease having at least 95% sequence identity with the amino acid sequence given in SEQ ID NO:1 over its entire length, and

(ii) substituting an amino acid at at least one of the positions corresponding to positions 101, 133, 144, 224, 252, or 271 in SEQ ID NO:1 in a starting protease having at least 95% sequence identity with the amino acid sequence given in SEQ ID NO:1 over its entire length.

6. The method according to claim 5 ,

wherein the substituting the at least one amino acid at the position corresponding to position 130 is N130D based on the numbering according to SEQ ID NO: 1 and occurs by one-time or multiple conservative amino acid substitution; and wherein the substituting the amino acid at at least one of the positions corresponding to positions 101, 133, 144, 224, 252, or 271 in SEQ ID NO:1 is D101E, T133R, N144K, S224A, N252T, or Q271E, respectively and

optionally altering the amino acid sequence by fragmentation or deletion, insertion or substitution mutagenesis such that the protease comprises an amino acid sequence matching the starting molecule over a length of at least 200, 210, 220, 230, 240, 250, 260, 270, or 275 contiguous amino acids.

7. A nucleic acid coding for a protease according to claim 1 .

8. A vector containing a nucleic acid according to claim 7 .

9. A non-human host cell containing a nucleic acid according to claim 7 .

10. A method for producing a protease, comprising

a) cultivating a host cell according to claim 9 ; and

b) isolating the protease from the culture medium or from the host cell.

11. A composition comprising:

at least one protease according to claim 1 ;

an agent comprising a washing agent, a cleaning agent, or combinations thereof; and

one or more surfactants.

12. The composition according to claim 11 , wherein the at least one amino acid substitution according to (b) is selected from the group consisting of D101E, T133R, N144K, S224A, N252T, Q271E, or combinations thereof in each case based on the numbering according to SEQ ID NO: 1.

13. The composition of claim 11 , wherein the protease comprises:

(A) one of the following amino acid substitution variants, in each case based on the numbering according to SEQ ID NO:1:

(v) D101E, N130D, T133R, S224A, and Q271E;

(vi) D101E, N130D, N144K, N252T, and Q271E;

(vii) N130D, N144K, N252T and Q271E; or

(viii) N130D, T133R, S224A and Q271E; and/or

(B) an amino acid sequence according to one of SEQ ID Nos. 2-5.

14. A nucleic acid coding for a protease that can be obtained by a method according to claim 5 .

15. An expression vector containing a nucleic acid according to claim 7 .

16. A non-human host cell containing a vector according to claim 8 .

17. A non-human host cell containing a protease according to claim 1 .

18. A non-human host cell containing a protease obtainable by the method of claim 5 .

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 12, 2020
From: MUSSMANN, NINA; WIELAND, SUSANNE; HERBST, DANIELA; PRUESER, INKEN
To: HENKEL AG & CO. KGAA
Reel/Frame 052092/0731 →
Priority Claims (1)
DE 10 2017 215 629.5 · Sep 5, 2017 · national
Continuity (1)
Related Publication 20200255773A1 · Aug 13, 2020
Cited By (1)
US 12,606,811